Cargando…

ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes

INTRODUCTION: Living with diabetes can be burdensome and lead to serious emotional distress and impaired mental health. Acceptance and commitment therapy (ACT) can support people facing the challenges of living with diabetes. This trial aims to evaluate the effectiveness and cost-effectiveness of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bendig, Eileen, Schmitt, Andreas, Wittenberg, Amelie, Kulzer, Bernhard, Hermanns, Norbert, Moshagen, Morten, Baumeister, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478835/
https://www.ncbi.nlm.nih.gov/pubmed/36109030
http://dx.doi.org/10.1136/bmjopen-2021-059336
_version_ 1784790662230573056
author Bendig, Eileen
Schmitt, Andreas
Wittenberg, Amelie
Kulzer, Bernhard
Hermanns, Norbert
Moshagen, Morten
Baumeister, Harald
author_facet Bendig, Eileen
Schmitt, Andreas
Wittenberg, Amelie
Kulzer, Bernhard
Hermanns, Norbert
Moshagen, Morten
Baumeister, Harald
author_sort Bendig, Eileen
collection PubMed
description INTRODUCTION: Living with diabetes can be burdensome and lead to serious emotional distress and impaired mental health. Acceptance and commitment therapy (ACT) can support people facing the challenges of living with diabetes. This trial aims to evaluate the effectiveness and cost-effectiveness of the internet-based and mobile-based intervention (IMI) ‘ACTonDiabetes’ in reducing diabetes distress against enhanced treatment as usual (TAU+) following specialised diabetes care. METHODS AND ANALYSIS: A two-armed pragmatic randomised controlled trial will be conducted to evaluate the guided IMI ACTonDiabetes against TAU+. A total of 210 adults with type 1 or type 2 diabetes and elevated diabetes distress (Problem Areas in Diabetes ≥40) will be recruited at a specialised diabetes centre. The intervention begins 2–4 weeks after hospital discharge and takes about 7–10 weeks to complete. Assessments are performed at baseline and 5 and 10 weeks as well as 6 and 12 months after randomisation. The primary outcome is diabetes distress at a 10-week follow-up (T2). Secondary outcomes are depression (Patient Health Questionnaire-8), psychological well-being (WHO-5), quality of life (Assessment of Quality of Life-8 Dimension), Diabetes-related Self-Management Questionnaire, diabetes acceptance (Acceptance and Action Diabetes Questionnaire) and negative treatment effects (Inventory for the Assessment of Negative Effects of Psychotherapy). All statistical analyses will be performed based on the intention-to-treat principle with additional per-protocol analyses. Changes in outcomes will be evaluated using the general linear model. A health-economic evaluation will be conducted from a societal perspective. Reasons for drop-out will be systematically investigated. ETHICS AND DISSEMINATION: This clinical trial has been approved by the State Medical Chamber of Baden-Württemberg (file no. B-F-2019-010). Trial results will be submitted for publication in a peer-reviewed journal and presented at conferences. TRIAL REGISTRATION NUMBER: DRKS00016738.
format Online
Article
Text
id pubmed-9478835
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94788352022-09-17 ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes Bendig, Eileen Schmitt, Andreas Wittenberg, Amelie Kulzer, Bernhard Hermanns, Norbert Moshagen, Morten Baumeister, Harald BMJ Open Mental Health INTRODUCTION: Living with diabetes can be burdensome and lead to serious emotional distress and impaired mental health. Acceptance and commitment therapy (ACT) can support people facing the challenges of living with diabetes. This trial aims to evaluate the effectiveness and cost-effectiveness of the internet-based and mobile-based intervention (IMI) ‘ACTonDiabetes’ in reducing diabetes distress against enhanced treatment as usual (TAU+) following specialised diabetes care. METHODS AND ANALYSIS: A two-armed pragmatic randomised controlled trial will be conducted to evaluate the guided IMI ACTonDiabetes against TAU+. A total of 210 adults with type 1 or type 2 diabetes and elevated diabetes distress (Problem Areas in Diabetes ≥40) will be recruited at a specialised diabetes centre. The intervention begins 2–4 weeks after hospital discharge and takes about 7–10 weeks to complete. Assessments are performed at baseline and 5 and 10 weeks as well as 6 and 12 months after randomisation. The primary outcome is diabetes distress at a 10-week follow-up (T2). Secondary outcomes are depression (Patient Health Questionnaire-8), psychological well-being (WHO-5), quality of life (Assessment of Quality of Life-8 Dimension), Diabetes-related Self-Management Questionnaire, diabetes acceptance (Acceptance and Action Diabetes Questionnaire) and negative treatment effects (Inventory for the Assessment of Negative Effects of Psychotherapy). All statistical analyses will be performed based on the intention-to-treat principle with additional per-protocol analyses. Changes in outcomes will be evaluated using the general linear model. A health-economic evaluation will be conducted from a societal perspective. Reasons for drop-out will be systematically investigated. ETHICS AND DISSEMINATION: This clinical trial has been approved by the State Medical Chamber of Baden-Württemberg (file no. B-F-2019-010). Trial results will be submitted for publication in a peer-reviewed journal and presented at conferences. TRIAL REGISTRATION NUMBER: DRKS00016738. BMJ Publishing Group 2022-09-14 /pmc/articles/PMC9478835/ /pubmed/36109030 http://dx.doi.org/10.1136/bmjopen-2021-059336 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Mental Health
Bendig, Eileen
Schmitt, Andreas
Wittenberg, Amelie
Kulzer, Bernhard
Hermanns, Norbert
Moshagen, Morten
Baumeister, Harald
ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes
title ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes
title_full ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes
title_fullStr ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes
title_full_unstemmed ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes
title_short ACTonDiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes
title_sort actondiabetes: study protocol of a pragmatic randomised controlled trial for the evaluation of an acceptance and commitment-based internet-based and mobile-based intervention for adults living with type 1 or type 2 diabetes
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478835/
https://www.ncbi.nlm.nih.gov/pubmed/36109030
http://dx.doi.org/10.1136/bmjopen-2021-059336
work_keys_str_mv AT bendigeileen actondiabetesstudyprotocolofapragmaticrandomisedcontrolledtrialfortheevaluationofanacceptanceandcommitmentbasedinternetbasedandmobilebasedinterventionforadultslivingwithtype1ortype2diabetes
AT schmittandreas actondiabetesstudyprotocolofapragmaticrandomisedcontrolledtrialfortheevaluationofanacceptanceandcommitmentbasedinternetbasedandmobilebasedinterventionforadultslivingwithtype1ortype2diabetes
AT wittenbergamelie actondiabetesstudyprotocolofapragmaticrandomisedcontrolledtrialfortheevaluationofanacceptanceandcommitmentbasedinternetbasedandmobilebasedinterventionforadultslivingwithtype1ortype2diabetes
AT kulzerbernhard actondiabetesstudyprotocolofapragmaticrandomisedcontrolledtrialfortheevaluationofanacceptanceandcommitmentbasedinternetbasedandmobilebasedinterventionforadultslivingwithtype1ortype2diabetes
AT hermannsnorbert actondiabetesstudyprotocolofapragmaticrandomisedcontrolledtrialfortheevaluationofanacceptanceandcommitmentbasedinternetbasedandmobilebasedinterventionforadultslivingwithtype1ortype2diabetes
AT moshagenmorten actondiabetesstudyprotocolofapragmaticrandomisedcontrolledtrialfortheevaluationofanacceptanceandcommitmentbasedinternetbasedandmobilebasedinterventionforadultslivingwithtype1ortype2diabetes
AT baumeisterharald actondiabetesstudyprotocolofapragmaticrandomisedcontrolledtrialfortheevaluationofanacceptanceandcommitmentbasedinternetbasedandmobilebasedinterventionforadultslivingwithtype1ortype2diabetes